Based on these data, therapy aimed at upregulating BCL6 expression may be significant in treating HFD-induced NAFLD.
← all excerpts
B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36.
1
—
—